Zobrazeno 1 - 10
of 16
pro vyhledávání: '"SILA AKHAN"'
Autor:
Mine Durusu Tanriover, Ozlem Altuntas Aydin, Rahmet Guner, Orhan Yildiz, Ilhami Celik, Sukran Kose, Sila Akhan, Emin Halis Akalin, Aykut Ozdarendeli, Serhat Unal, Ihsan Ates, Ates Kara
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
This study- a secondary analysis of data from a randomized, observer-blinded, non-inferiority study among volunteers between 18–55 y old in Türkiye- evaluated the impact of previous SARS-CoV-2 infection before the first dose of inactive TURKOVAC o
Externí odkaz:
https://doaj.org/article/99e01bd476994f92ba56843b38725bcf
Publikováno v:
Journal of Nature and Science of Medicine, Vol 6, Iss 1, Pp 32-37 (2023)
Objective: The aim of this study is to reveal the relationship between the cytokine plasma levels and symptoms of coronavirus disease-2019 (COVID-19)-positive patients, which is characterized by serious respiratory syndromes. Materials and Methods: S
Externí odkaz:
https://doaj.org/article/995e6236358642a8a4d9e9294b513ba7
Autor:
Mine Durusu Tanriover, Ozlem Altuntas Aydin, Rahmet Guner, Orhan Yildiz, Ilhami Celik, Hamdi Levent Doganay, Sukran Kose, Sila Akhan, Emin Halis Akalin, Zafer Sezer, Aykut Ozdarendeli, Serhat Unal, on behalf of the TURKOVAC Study Group
Publikováno v:
Vaccines, Vol 10, Iss 11, p 1865 (2022)
We present the interim results of the efficacy, immunogenicity, and safety of the two-dose schedules of TURKOVAC versus CoronaVac. This was a randomized, observer-blinded, non-inferiority trial (NCT04942405). Volunteers were 18–55 years old and ran
Externí odkaz:
https://doaj.org/article/439a76f936ab4b1a84e0b1a3d91c8b7c
Autor:
Seyfettin Köklü, Iftihar Köksal, Ulus Salih Akarca, Ayhan Balkan, Rahmet Güner, Aylin Demirezen, Memduh Sahin, Sila Akhan, Reşat Ozaras, Ramazan Idilman
Publikováno v:
Annals of Hepatology, Vol 16, Iss 1, Pp 71-76 (2017)
Background: Daclatasvir and asunaprevir dual therapy is approved for the treatment of HCV genotype 1b infection in several countries. Aim: To evaluate the efficacy and safety of daclatasvir and asunaprevir dual therapy in Turkish patients. Material a
Externí odkaz:
https://doaj.org/article/e964067c9484470b8df0e894038dfe1c
Autor:
Elif Sargin Altunok, Murat Sayan, Sila Akhan, Bilgehan Aygen, Orhan Yildiz, Suda Tekin Koruk, Resit Mistik, Nese Demirturk, Onur Ural, Şükran Kose, Aynur Aynioglu, Fatime Korkmaz, Gülden Ersoz, Nazan Tuna, Celal Ayaz, Faruk Karakecili, Derya Keten, Dilara Inan, Saadet Yazici, Safiye Koculu, Taner Yildirmak
Publikováno v:
International Journal of Infectious Diseases, Vol 50, Iss C, Pp 1-5 (2016)
Background: Drug resistance development is an expected problem during treatment with protease inhibitors (PIs), this is largely due to the fact that Pls are low-genetic barrier drugs. Resistance-associated variants (RAVs) however may also occur natur
Externí odkaz:
https://doaj.org/article/746674f3f2674d80aa0bd064e45cced1
Publikováno v:
Eastern Mediterranean Health Journal. 29:91-99
Background: Antibody testing can complement molecular assays for detecting COVID-19. Aims: We evaluated the concurrence between lateral flow assay and enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies in severe acute respirato
Publikováno v:
Current HIV Research. 20:184-192
Background and Objective: Integrase strand transfer inhibitors (INSTIs) are currently the standard of practice for first-line HIV therapy for most patients. We evaluated the mutations associated with INSTI resistance in naive HIV-1 infected patients
Autor:
Sila Akhan, Aynur Aynioglu, Atahan Cagatay, Ibak Gonen, Ozgur Gunal, Teoman Kaynar, Ziya Kuruuzum, Murat Sayan, Berivan Tunca, Necla Tulek, Huseyin Uckardes, Ayse Yavuz, Orhan Yildiz, Neziha Yilmaz, Esma Yuksel
Publikováno v:
Klimik Dergisi/Klimik Journal. 27:2-18
Autor:
İftihar KÖKSAL, GÜRDAL YILMAZ, Mehmet PARLAK, Tuna DEMİRDAL, Sami KINIKLI, MEHMET CANDAN, Ali KAYA, SILA AKHAN, Özcan AYDOĞDU, Hüseyin TURGUT, Yunus GÜRBÜZ, Özgür DAĞLI, Ahmet Ali GÖKAL, Rahmet GÜNER, ZİYA KURUÜZÜM, Hüseyin TARAKÇI, Nuri BESLEN, Seda ERDOĞAN, FATİH ÖZDENER
Background/Aims: The hepatitis C virus (HCV) infection is important cause of chronic hepatitis. Liver biopsy is considered the gold standard for assessment of fibrosis but this procedure is an invasive procedure. We aimed to evaluate the diagnostic e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3566::7446fb9189ae42d4322e8398b445c340
Publikováno v:
Mediterranean Journal of Infection, Microbes and Antimicrobials, Vol 12, Iss 1 (2023)
Introduction: Coronavirus disease-2019 (COVID-19) has affected more than 676 million people till date, and 6,881,955 people have died from the disease as of March 28, 2023. Understanding the immunopathogenesis of the disease has led to more vaccine s
Externí odkaz:
https://doaj.org/article/64523ce6f029463ebc78294c294f8c98